In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
Ann Intern Med
; 174(3): JC29, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-1112857
ABSTRACT
SOURCE CITATION Voysey M, Clemens SA, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2 an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;39799-111. 33306989.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
Type of study:
Experimental Studies
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Adult
/
Humans
Country/Region as subject:
Africa
/
South America
/
Brazil
/
Europa
Language:
English
Journal:
Ann Intern Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS